Nitric oxide (NO) - a wide-range modulator of life’s processes.The role in pathomechanism of alcohol addiction and withdrawal symptoms

Authors

  • Agnieszka Pedrycz Department of Histology and Embryology with Laboratory of Experimental Cytology, Medical University of Lublin, 20-080 Lublin, Poland Author
  • Alicja Ciechan WSPRiTS SP ZOZ” in Lublin, Poland Author
  • Piotr Siermontowski Military Institute of Medicine, Maritime & Hyperbaric Medicine Department, Gdynia Poland Author
  • Dorota Polz Departament of Virology, Medical University of Lublin, Lublin, Poland Author

Keywords:

nitric oxide, mechanisms of NO action, alcohol addiction, withdrawal symptoms

Abstract

Introduction and aim: The aim of this study was to analyze the available literature in terms of understanding the functions and mechanisms of endo-and exogenous nitric oxide (NO). Particular attention was paid to the in-volvement of nitric oxide donors in the pathogenesis of alcohol dependence and withdrawal syndrome.

Results and discussion: Nitric oxide was discovered in 1770. Numerous studies about NO biochemistry have been carried out since that time In 1998 Robert F. Furchgott, Luis Ignarro and Ferid Murad received the Nobel Prize in medicine for their research on the sequence of metabolic changes: L-arginine → NO. There are various mechanisms leading to the activation of individual NOS isoforms and thus to NO synthesis. Moreover, NO formed in the reaction catalyzed by different NOS, has various functions. Excessive endogenous NO is involved in the pathogenesis of many diseases, e.g. atherosclerosis, degenerative diseases of the nervous system, inflammations, autoimmune diseases and cancers. Deficient endogenous NO is implicated in the development of hypertension, preeclampsia, arteriosclerosis, hypercholesterolemia. Exogenous NO is administered to patients with venous atheros-clerosis of the lower limbs, coronary disease and pregnancy-induced hypertension. An increase or a slight decrease in NO metabolites plasma concentration following 4-week abstinence may be a predictor of alcohol drinking relapse during the next five months. 

References

1. Maleck W.H., Piper S.N., Koetter K. Joseph Priestley, nitrous oxide and oxygen. Anaesthesist, 2005; 54: 395-396.

2. Sternbach G.L., Varon J. The discovery and rediscovery of oxygen. J Emerg Med. 2005; 28: 221-4.

3. Severinghaus J.W. Fireair and dephlogistication. Revisionisms of oxygen’s discovery. Adv. Exp. Med. Biol., 2003; 543: 7-19.

4. Marsh N., Marsh A. A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin. Exp. Pharmacol. Physiol., 2000; 27: 313-319.

5. Katsuki S., Arnold W., Mittal C., Murand F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azine and hydroxylamine. Cyclic Nucleotide Res., 1977; 3: 23-35.

6. De Berrazueta J.R. The Nobel Prize for nitric oxide. The unjust exclusion of dr. Salvador Moncada. Rev. Esp. Cardiol., 1999; 52: 221-226.

7. Furchgott R.F. Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci. Rep., 1999; 19: 235-251.

8. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Nat. Acad. Sci. USA, 1987; 84: 9265-9269.

9. Poderoso J.J. Nobel Prize in medicine 1998: resurrection of an inorganic gas into a molecule of high biological significance. Medicina, 1999; 59: 205-207.

10. Moncada S., Higgs A. Mechanism of disease: L-arginine-nitric oxide pathway. N. Engl. J. Med., 1994; 329: 2002-2012.

11. Garthwaite G., Batchelor A.M., Goodwin D.A., Hewson A.K., Leerning K., Ahmed Z., Cuzner M.L., Garthwaite J. Pathological implications of iNOS expression in central white matter: an ex vivo study of optic nerves from rats with experimental allergic encephalomyelitis. Eur. J. Neurosci., 2005; 21: 2127-2135.

12. Rytlewski K., Zdebski Z. Nitric oxide - one of the mechanisms that prevent changes that occur during pregnancy. Gin. Pol., 2001; 72: 738-743.

13. Korbut R., Trabka-Janik E., Gryglewski R.J. Cytoprotection of human polymorphonuclear leukocytes by stimulators of adenylate and guanylate cyclases. Eur. J. Pharmacol., 1989; 165: 171-172.

14. Hecker M., Mitchell J.A., Swierkosz T.A., Sessa W.C., Vane JR Inhibition of l-glutamine fo the relears of endo-thelium-derived relaxing factor from cultured endothelial cells. Br. J. Pharmacol., 1990; 101: 237-239.

15. Francisco Y.A., Dantas A.P., Carvalho M.H., Laurindo F.R. Estrogen enhances vasoconstrictive remodeling after injury in male rabbits. Braz. J. Med. Biol. Res., 2005; 38: 1325-1329.

16. Geller D.A., Lowenstein C.J., Shapiro R.A., Nussler A.K., Di Silvio M., Wang S.C., Nakayama D.K., Simmons R.L., Snyder S.H., Billiar T.R. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA, 1993; 90: 3491-3495.

17. Seidel M., Kurpisz M. Endoteilalna syntaza tlenku azotu CZ. I. Struktura genu i produktu białkowego. Post. Biol. Kom., 2004; 31: 465-447.

18. Shin C.Y., Choi J.W., Ryu J.R., Ko K.H., Choi J.J., Kim H.S., Lee J.C., Lee S.J., Kim H.C., Kim W.K. Glucose deprivation decreases nitric oxide production via NADPH depletion in immunostimulated rat primary ast-rocytes. Glia., 2002; 37: 268-274.

19. Gauthier K.M., Zhang D.X., Ewards E.M., Holmes B., Campbell W.B. Angiotensin II dilates bovine adrenal cortical arterioles: role of endothelial nitric oxide. Endocriniolgy, 2005; 146: 3319-3324.

20. Broillet M.C. S-nitrosylation of proteins. Cell. Mol. Life Sci., 1999; 55: 1036-1042.

21. Aricioglu F., Paul I.A., Regunathan S. Agmatine reduces only peripheral-related behavioral signs, not the central signs, of morphine withdrawal in nNOS deficient transgenic mice. Neurosci. Lett., 2004; 354: 153-157. 22. Klamer D., Palsson E., Revesz A., Engel J.A., Svensson L. Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory mechanisms. Psychopharmacology, 2004.

23. Budzyński J., Kłopocka M., Świątkowski M., Ziółkowski M., Pulkowski G., Kopczyńska E. Nitric oxide metabolites plasma level in alcohol dependent male patients during six-month abstinence. Alkoholizm i Narkomania, 2004; 17: 197-209.

24. Budzyński J., Kłopocka M., Świątkowski M., Ziółkowski M., Pulkowski G., Kopczyńska E. Can an increase of nitric oxide metabolites concentration after first four weeks of abstinence predict alcohol relapse during the next five months? Alkoholizm i Narkomania, 2004; 17: 211-220.

Downloads

Published

2011-01-27